Baird Financial Group, Inc. Novartis Ag Transaction History

Baird Financial Group, Inc.

  • $47.6 Billion
  • Q2 2024

A detailed history of Baird Financial Group, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Baird Financial Group, Inc. holds 87,284 shares of NVS stock, worth $9.65 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
87,284
Previous 81,640 6.91%
Holding current value
$9.65 Million
Previous $7.9 Million 17.66%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$92.57 - $107.37 $522,465 - $605,996
5,644 Added 6.91%
87,284 $9.29 Million
Q1 2024

May 14, 2024
BUY
$95.27 - $108.47 $570,286 - $649,301
5,986 Added 7.91%
81,640 $7.9 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $207,238 - $228,058
2,246 Added 3.06%
75,654 $7.64 Million
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $324,544 - $360,175
-3,426 Reduced 4.46%
73,408 $7.48 Million
Q2 2023

Aug 11, 2023
BUY
$92.52 - $104.91 $480,641 - $545,007
5,195 Added 7.25%
76,834 $7.75 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $104,119 - $120,745
-1,301 Reduced 1.78%
71,639 $6.59 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $439,676 - $514,223
-5,893 Reduced 6.2%
89,218 $6.78 Million
Q2 2022

Aug 08, 2022
SELL
$80.52 - $93.75 $29,470 - $34,312
-366 Reduced 0.38%
95,111 $8.04 Million
Q1 2022

May 13, 2022
BUY
$80.11 - $90.62 $330,213 - $373,535
4,122 Added 4.51%
95,477 $8.38 Million
Q4 2021

Feb 09, 2022
SELL
$79.7 - $88.13 $15,063 - $16,656
-189 Reduced 0.21%
91,355 $7.99 Million
Q3 2021

Nov 12, 2021
BUY
$81.78 - $95.14 $109,830 - $127,773
1,343 Added 1.49%
91,544 $7.49 Million
Q2 2021

Aug 11, 2021
BUY
$85.24 - $94.15 $13,808 - $15,252
162 Added 0.18%
90,201 $8.23 Million
Q1 2021

May 13, 2021
BUY
$83.5 - $98.47 $169,505 - $199,894
2,030 Added 2.31%
90,039 $7.7 Million
Q4 2020

Feb 11, 2021
BUY
$78.07 - $94.43 $324,146 - $392,073
4,152 Added 4.95%
88,009 $8.31 Million
Q3 2020

Nov 12, 2020
BUY
$82.14 - $91.0 $113,188 - $125,398
1,378 Added 1.67%
83,857 $7.29 Million
Q2 2020

Oct 22, 2020
SELL
$80.93 - $91.1 $93,312 - $105,038
-1,153 Reduced 1.38%
82,479 $7.2 Million
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $642,503 - $723,242
-7,939 Reduced 8.67%
83,632 $7.9 Million
Q1 2020

May 14, 2020
BUY
$70.67 - $99.01 $642,248 - $899,802
9,088 Added 11.02%
91,571 $7.55 Million
Q4 2019

Feb 14, 2020
SELL
$84.35 - $95.37 $210,959 - $238,520
-2,501 Reduced 2.94%
82,483 $7.81 Million
Q3 2019

Nov 14, 2019
SELL
$85.54 - $94.26 $1.05 Million - $1.16 Million
-12,315 Reduced 12.66%
84,984 $7.39 Million
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $1.87 Million - $2.3 Million
24,767 Added 34.15%
97,299 $8.88 Million
Q1 2019

May 14, 2019
SELL
$75.32 - $86.15 $350,237 - $400,597
-4,650 Reduced 6.02%
72,532 $6.97 Million
Q4 2018

Feb 14, 2019
BUY
$73.66 - $82.02 $7,366 - $8,202
100 Added 0.13%
77,182 $6.62 Million
Q3 2018

Nov 13, 2018
SELL
$66.94 - $77.43 $72,027 - $83,314
-1,076 Reduced 1.38%
77,082 $6.66 Million
Q2 2018

Aug 13, 2018
SELL
$64.91 - $73.36 $2.26 Million - $2.56 Million
-34,874 Reduced 30.85%
78,158 $5.9 Million
Q1 2018

May 14, 2018
BUY
$70.39 - $84.15 $668,845 - $799,593
9,502 Added 9.18%
113,032 $9.14 Million
Q4 2017

Feb 09, 2018
BUY
$72.33 - $77.64 $770,676 - $827,254
10,655 Added 11.47%
103,530 $8.69 Million
Q3 2017

Nov 14, 2017
SELL
$74.14 - $77.27 $7,191 - $7,495
-97 Reduced 0.1%
92,875 $7.97 Million
Q2 2017

Aug 14, 2017
BUY
N/A
92,972
92,972 $7.76 Million

Others Institutions Holding NVS

# of Institutions
1,434
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.55M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email